SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-281651
Filing Date
2014-07-28
Accepted
2014-07-28 11:02:39
Documents
10
Period of Report
2014-07-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d762605d8k.htm 8-K 15630
2 EX-10.1 d762605dex101.htm EX-10.1 447926
3 GRAPHIC g762605exa_pg063.jpg GRAPHIC 172512
4 GRAPHIC g762605exa_pg064.jpg GRAPHIC 201600
5 GRAPHIC g762605exa_pg066.jpg GRAPHIC 46738
6 GRAPHIC g762605exa_pg067.jpg GRAPHIC 54668
7 GRAPHIC g762605exa_pg072.jpg GRAPHIC 106180
8 GRAPHIC g762605exa_pg073.jpg GRAPHIC 42995
9 GRAPHIC g762605exa_pg079.jpg GRAPHIC 63348
10 GRAPHIC g762605exa_pg094.jpg GRAPHIC 273984
  Complete submission text file 0001193125-14-281651.txt   1791367
Mailing Address 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 14995854
SIC: 2834 Pharmaceutical Preparations